United States · FDA National Drug Code directory
Naproxen Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62207-728_f4026a0a-c9cd-3850-e053-2995a90a459c
- Product NDC
- 62207-728
- Form
- TABLET
- Composition / generic term
- Naproxen Sodium
- Labeler
- Granules India Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180608
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 24 TABLET in 1 BOTTLE (62207-728-24) · 62207-728-24
- 50 TABLET in 1 BOTTLE (62207-728-42) · 62207-728-42
- 100 TABLET in 1 BOTTLE (62207-728-43) · 62207-728-43
- 500 TABLET in 1 BOTTLE (62207-728-47) · 62207-728-47
- 1000 TABLET in 1 BOTTLE (62207-728-49) · 62207-728-49
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →